Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest update is out from JINS HOLDINGS ( (JP:3046) ).
JINS HOLDINGS reported that its consolidated results for the six months ended February 28, 2026, fell short of prior forecasts, with net sales, operating profit, ordinary profit, and profit attributable to owners of parent all coming in modestly below expectations. The shortfall was mainly driven by weaker-than-expected performance in the domestic eyewear business, where some products missed sales targets, though this was partially offset by stronger overseas results, including a recovery in China and solid expansion in Taiwan.
Reflecting the first-half underperformance, the company trimmed its full-year forecast for the fiscal year ending August 31, 2026, lowering projected net sales and profits by around 1–2 percent versus earlier guidance, though earnings are still expected to rise year on year. Management views the domestic weakness as a one-off factor and has left second-half assumptions unchanged, signaling confidence in a recovery while acknowledging near-term pressure on profitability and expectations for stakeholders.
The most recent analyst rating on (JP:3046) stock is a Hold with a Yen5348.00 price target. To see the full list of analyst forecasts on JINS HOLDINGS stock, see the JP:3046 Stock Forecast page.
More about JINS HOLDINGS
JINS HOLDINGS Inc. is a Japan-based eyewear company listed on the TSE Prime Market that designs, manufactures, and retails eyeglasses. The group operates both domestic and overseas businesses, with a growing presence in markets such as China and Taiwan, where it is expanding beyond major urban centers into regional areas to drive further growth.
Average Trading Volume: 212,226
Technical Sentiment Signal: Hold
Current Market Cap: Yen126B
For a thorough assessment of 3046 stock, go to TipRanks’ Stock Analysis page.

